Evidence map›Paper›PMID 12356729›Full record

ArticleThe EMBO journal2002

Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo.

Stephen J Zoog, Jennifer J Schiller, Justin A Wetter, Nor Chejanovsky, Paul D Friesen

Abstract read
In one paragraph

Article in The EMBO journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Stephen J ZoogInstitute for Molecular Virology, and Department of Biochemistry, Graduate School and College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Jennifer J Schiller
Justin A Wetter
Nor Chejanovsky
Paul D Friesen
University of Wisconsin–Madison · USAgricultural Research Organization · ILBoehringer Ingelheim (Germany) · DEMedical College of Wisconsin · US

Funding

GRADUATE TRAINING IN MOLECULAR BIOSCIENCEST32GM007215 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HULL, CHRISTINA M · 1985 to 2018
$22.5M
REGULATION OF VIRUS-INDUCED PROGRAMMED CELL DEATHR01AI040482 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI FRIESEN, PAUL D · 1997 to 2007
$1.6M
VIRAL ONCOLOGYT32CA009075 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI MERTZ, JANET ELAINE · 1985 to 2005
$1.1M
REGULATION OF VIRUS-INDUCED PROGRAMMED CELL DEATHR56AI040482 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI FRIESEN, PAUL D · 2010 to 2010
$290k
NCI NIH HHS CA 09075NCI NIH HHS T32 CA009075NIAID NIH HHS AI 40482NIAID NIH HHS R01 AI040482NIAID NIH HHS R56 AI040482NIGMS NIH HHS GM 07215NIGMS NIH HHS T32 GM007215
6 · The paper itself

Abstract

Caspases play a critical role in the execution of metazoan apoptosis and are thus attractive therapeutic targets for apoptosis-associated diseases. Here we report that baculovirus P49, a homolog of pancaspase inhibitor P35, prevents apoptosis in invertebrates by inhibiting an initiator caspase that is P35 insensitive. Consequently P49 blocked proteolytic activation of effector caspases at a unique step upstream from that affected by P35 but downstream from inhibitor of apoptosis Op-IAP. Like P35, P49 was cleaved by and stably associated with its caspase target. Ectopically expressed P49 blocked apoptosis in cultured cells from a phylogenetically distinct organism, Drosophila melanogaster. Furthermore, P49 inhibited human caspase-9, demonstrating its capacity to affect a vertebrate initiator caspase. Thus, P49 is a substrate inhibitor with a novel in vivo specificity for a P35-insensitive initiator caspase that functions at an evolutionarily conserved step in the caspase cascade. These data indicate that activated initiator caspases provide another effective target for apoptotic intervention by substrate inhibitors.

Indexed as

Caspase InhibitorsApoptosisBaculoviridaeCaspase 3Caspase 9Enzyme InhibitorsHumansViral ProteinsCASP3 protein, humanCASP9 protein, humanCaspase 3Caspase 9Caspase InhibitorsEnzyme InhibitorsP49 protein, Spodoptera littoralis nucleopolyhedrovirusViral Proteins

Identifiers

PMID12356729
PMCPMC129042
OpenAlexW1981297653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.